AFT Pharmaceuticals hits $200m revenue milestone despite profit dip
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
Infratil and Ebos help drive NZ stocks higher
Infrastructure investor helped the sharemarket end the week on a positive note.
Tāmaki Health appoints advisers amid investor interest
The company's received numerous approaches from interested parties, CEO says.
NZ is off track on emissions targets: CCC
The Government will need new policies to cover the emissions target gap.
Global real estate without the passport or paperwork
A global ETF offers access to income-generating real estate like data centres, healthcare and logistics warehouses – all in New Zealand dollars.
‘Make Today the Day’: Why on-the-job training is the key to NZ’s service recovery
Covid gutted New Zealand’s service workforce. Training is the fix – and the future.
